Total Payments
$3,364
2024 Payments
$197.24
Companies
22
Transactions
83
Medicare Patients
1,096
Medicare Billing
$201,717
Payment Breakdown by Category
Food & Beverage$3,299 (98.1%)
Gifts$59.40 (1.8%)
Education$6.02 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,299 | 81 | 98.1% |
| Gift | $59.40 | 1 | 1.8% |
| Education | $6.02 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $834.88 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $534.99 | 11 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $476.73 | 8 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $275.41 | 13 | $0 (2020) |
| GlaxoSmithKline, LLC. | $243.46 | 2 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $235.08 | 8 | $0 (2020) |
| PFIZER INC. | $113.49 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $100.00 | 1 | $0 (2018) |
| LivaNova USA, Inc. | $84.54 | 1 | $0 (2017) |
| UCB, Inc. | $73.92 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197.24 | 9 | Novo Nordisk Inc ($73.06) |
| 2023 | $258.81 | 8 | Novo Nordisk Inc ($133.43) |
| 2022 | $185.26 | 4 | GlaxoSmithKline, LLC. ($124.73) |
| 2020 | $132.07 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($34.77) |
| 2019 | $247.83 | 9 | Janssen Pharmaceuticals, Inc ($90.00) |
| 2018 | $1,314 | 18 | SANOFI-AVENTIS U.S. LLC ($396.72) |
| 2017 | $1,029 | 27 | Janssen Pharmaceuticals, Inc ($381.64) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $32.94 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.24 | General |
| 07/08/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Neurology | ||||||
| 06/11/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $28.49 | General |
| Category: Endocrinology | ||||||
| 03/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.60 | General |
| Category: Insulin Pump | ||||||
| 01/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Diabetes | ||||||
| 10/10/2023 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/23/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $6.36 | General |
| 08/23/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $0.95 | General |
| 07/14/2023 | Medtronic, Inc. | LINQ II (Device) | Food and Beverage | In-kind items and services | $51.46 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 05/22/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $30.16 | General |
| Category: Endocrinology | ||||||
| 04/17/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $28.81 | General |
| Category: Neurology | ||||||
| 03/16/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $109.96 | General |
| Category: Obesity | ||||||
| 11/02/2022 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $24.55 | General |
| Category: Neurology | ||||||
| 08/02/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Endocrinology | ||||||
| 05/26/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: IMMUNOLOGY | ||||||
| 02/15/2022 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/07/2020 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.03 | General |
| 07/03/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: STRUCTURAL HEART | ||||||
| 03/09/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: DIABETES | ||||||
| 02/26/2020 | CSL Behring | Haegarda (Biological) | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 338 | 521 | $112,125 | $56,572 |
| 2022 | 5 | 266 | 410 | $91,525 | $46,673 |
| 2021 | 7 | 252 | 510 | $99,625 | $48,934 |
| 2020 | 7 | 240 | 698 | $125,525 | $49,538 |
Total Patients
1,096
Total Services
2,139
Medicare Billing
$201,717
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 174 | 242 | $60,500 | $29,284 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 122 | $21,350 | $14,294 | 66.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 72 | $10,800 | $5,735 | 53.1% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 61 | 71 | $15,975 | $5,149 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $3,500 | $2,111 | 60.3% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 103 | 133 | $33,250 | $14,796 | 44.5% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 63 | 92 | $27,600 | $13,828 | 50.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 81 | $14,175 | $9,575 | 67.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 92 | $13,800 | $7,492 | 54.3% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Facility | 2022 | 12 | 12 | $2,700 | $981.84 | 36.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 188 | $28,200 | $15,417 | 54.7% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 88 | 110 | $27,500 | $13,217 | 48.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 118 | $20,650 | $7,974 | 38.6% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 23 | 28 | $8,400 | $4,367 | 52.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 20 | 32 | $5,600 | $3,864 | 69.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 19 | $6,650 | $2,449 | 36.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $2,625 | $1,644 | 62.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 34 | 382 | $66,850 | $25,531 | 38.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 68 | 154 | $23,100 | $9,848 | 42.6% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2020 | 51 | 66 | $16,500 | $7,900 | 47.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 34 | 35 | $12,250 | $4,543 | 37.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 25 | 29 | $3,625 | $1,032 | 28.5% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 12 | 15 | $1,500 | $524.89 | 35.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 16 | 17 | $1,700 | $160.36 | 9.4% |
About Zia Ahmed
Zia Ahmed is a Endocrinology, Diabetes & Metabolism healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083659239.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Zia Ahmed has received a total of $3,364 in payments from pharmaceutical and medical device companies, with $197.24 received in 2024. These payments were reported across 83 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,299).
As a Medicare-enrolled provider, Ahmed has provided services to 1,096 Medicare beneficiaries, totaling 2,139 services with total Medicare billing of $201,717. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Internal Medicine
- Location Brooklyn, NY
- Active Since 06/19/2006
- Last Updated 02/02/2026
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1083659239
Products in Payments
- INVOKANA (Drug) $465.62
- JARDIANCE (Drug) $299.00
- Ozempic (Drug) $298.65
- SOLIQUA (Drug) $271.72
- Victoza (Drug) $227.12
- ELIQUIS (Drug) $213.49
- TOUJEO (Drug) $185.80
- NUCALA (Biological) $124.73
- STEGLATRO (Drug) $123.43
- BEXSERO (Biological) $118.73
- JANUVIA (Drug) $111.65
- Wegovy (Drug) $109.96
- Tresiba (Drug) $109.30
- VNS Therapy (Device) $84.54
- XARELTO (Drug) $63.35
- AFREZZA (Drug) $59.40
- Briviact (Drug) $53.36
- LINQ II (Device) $51.46
- Dexcom G6 Transmitter (Medical Supply) $48.14
- UNITHROID (Drug) $32.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Brooklyn
Dr. Matin Sharafatkhah, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $437,076
Endocrinology, Diabetes & Metabolism $437,076
Dr. Matvey Brokhin, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $373,852
Endocrinology, Diabetes & Metabolism $373,852
Dr. Robert Silver, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $354,536
Endocrinology, Diabetes & Metabolism $354,536
Alexander Perkelvald, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $343,784
Endocrinology, Diabetes & Metabolism $343,784
Dr. Iraklii Buziashvili, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $122,903
Endocrinology, Diabetes & Metabolism $122,903
Dr. Saka Kazeem, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $23,364
Endocrinology, Diabetes & Metabolism $23,364